Lupus anticoagulant in patients with COVID-19: A review
Introduction: Coronavirus disease 2019 (COVID-19) is characterized by a pro-coagulant state that can lead to fatal thromboembolic events. A high prevalence of lupus anticoagulant has been shown in several studies that may at least partially explain the pro-coagulant profile of COVID-19. However, the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2021-01-01
|
| Series: | Journal of Preventive Epidemiology |
| Subjects: | |
| Online Access: | https://jprevepi.com/PDF/jpe-6-e07.pdf |